LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 24 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $8,490,000 | +3.4% | 5,700,000 | 0.0% | 2.38% | -3.8% |
| Q4 2016 | $8,208,000 | +52.7% | 5,700,000 | +54.1% | 2.47% | +118.1% |
| Q3 2016 | $5,377,000 | -13.0% | 3,700,000 | 0.0% | 1.13% | -15.6% |
| Q2 2016 | $6,178,000 | +9.5% | 3,700,000 | 0.0% | 1.34% | -9.3% |
| Q1 2016 | $5,642,000 | – | 3,700,000 | – | 1.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opera Trading Capital | 5,700,000 | $8,208,000 | 2.47% |
| TFG Asset Management GP Ltd | 8,100,000 | $11,729,000 | 2.33% |
| Mint Tower Capital Management B.V. | 4,500,000 | $6,507,000 | 2.17% |
| BASSO CAPITAL MANAGEMENT, L.P. | 8,010,000 | $11,584,000 | 1.75% |
| CQS Cayman LP | 15,000,000 | $21,717,000 | 1.72% |
| LINDEN ADVISORS LP | 21,855,000 | $31,633,000 | 1.23% |
| CAMDEN ASSET MANAGEMENT L P /CA | 22,575,000 | $32,593,000 | 0.92% |
| Myriad Asset Management Ltd. | 9,000,000 | $13,045,000 | 0.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 25,000,000 | $36,172,000 | 0.64% |
| CSS LLC/IL | 5,500,000 | $7,955,000 | 0.43% |